Between HCA’s clinical expertise, ability to implement interventions and informatics capabilities, and the Institute’s research capabilities and investigators, the partnership is expected to lead to numerous research initiatives.
Under the partnership, both organizations will expand the study of healthcare-associated infections and medical product safety surveillance, as well as delve into maternal-child care and pharmacy research.
Richard Platt, MD, professor and chair of the Harvard Medical School Department of Population Medicine at the Harvard Pilgrim Health Care Institute expressed excitement over the pending partnership.
“HCA’s extensive hospital network and the quality of its electronic health records can significantly improve our shared ability to answer important research questions,” he said.
Jonathan B. Perlin, MD, PhD, president of clinical services group and CMO at HCA, echoed Dr. Platt’s positive sentiments.
“Our unprecedented partnership has already yielded information that not only makes preventing [methicillin-resistant Staphylococcus aureus] and other serious infections simpler and more effective, it helped set a new standard for responsible infection prevention,” said Dr. Perlin. ”Future research projects will advance the learning health care system by making evidence development an expected part of care delivery.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
